Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes

被引：0
|
作者：
Boris Kovatchev
Zhaoling Meng
Anna M. G. Cali
Riccardo Perfetti
Marc D. Breton
机构：
[1] University of Virginia,Center for Diabetes Technology
[2] Sanofi,undefined
[3] Sanofi,undefined
来源：
Diabetes Therapy | 2020年 / 11卷
关键词：
Basal insulin; Glycaemic variability; Hypoglycaemia; Insulin glargine; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1293 / 1302
页数：9
相关论文
共 50 条
  • [21] In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes
    Schiavon, Michele
    Visentin, Roberto
    Giegerich, Clemens
    Sieber, Jochen
    Dalla Man, Chiara
    Cobelli, Claudio
    Klabunde, Thomas
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (08) : 553 - 561
  • [22] Glycaemic control, hypoglycaemia, and weight change with insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Japanese adults with type 2 diabetes: A 12-month comparison by concomitant sulphonylurea and/or glinide use
    Terauchi, Yasuo
    Riddle, Matthew C.
    Hirose, Takahisa
    Koyama, Masayoshi
    Cheng, Xi
    Takahashi, Yoshinori
    Bolli, Geremia B.
    DIABETES OBESITY & METABOLISM, 2018, 20 (11): : 2541 - 2550
  • [23] Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin-naive people with type 2 diabetes: The EDITION AP randomized controlled trial
    Ji, Linong
    Kang, Eun Seok
    Dong, XiaoLin
    Li, Ling
    Yuan, GuoYue
    Shang, Shuhua
    Niemoeller, Elisabeth
    DIABETES OBESITY & METABOLISM, 2020, 22 (04): : 612 - 621
  • [24] INSULIN GLARGINE 300 U/ML IS ASSOCIATED WITH LESS WEIGHT GAIN WHILE MAINTAINING GLYCEMIC CONTROL AND LOW RISK OF HYPOGLYCEMIA COMPARED WITH INSULIN GLARGINE 100 U/ML IN AN AGING POPULATION WITH TYPE 2 DIABETES
    Munshi, Medha N.
    Gill, Jasvinder
    Chao, Jason
    Nikonova, Elena V.
    Patel, Meenakshi
    ENDOCRINE PRACTICE, 2018, 24 (02) : 143 - 149
  • [25] REDUCED HYPOGLYCEMIA AND COMPARABLE EFFICACY WITH INSULIN GLARGINE 300 U/ML VERSUS INSULIN GLARGINE 100 U/ML IN PATIENTS WITH TYPE 2 DIABETES ACHIEVING DIFFERENT LEVELS OF PREBREAKFAST SELF-MONITORED PLASMA GLUCOSE
    Bailey, Timothy S.
    Odugbesan, Ola
    Gill, J. K.
    Nikonova, Elena, V
    Chao, Jason
    Reid, Timothy
    ENDOCRINE PRACTICE, 2018, 24 (11) : 973 - 981
  • [26] Comparative clinical efficacy and safety of insulin glargine 300 U/ml (Toujeo) versus insulin glargine 100 U/ml in type 2 diabetes and type 1 diabetes: A systematic literature review and meta-analysis
    Joshi, Shashank R.
    Singh, Gursharan
    Marwah, Ashwani
    Mittra, Shivani
    Suvarna, Viraj R.
    Athalye, Sandeep N.
    DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1589 - 1606
  • [27] Sustained glycaemic control and less nocturnal hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml over 1 year in Japanese people with type 1 diabetes mellitus
    Matsuhisa, M.
    Koyama, M.
    Cheng, X.
    Sumi, M.
    Hirose, T.
    DIABETOLOGIA, 2015, 58 : S2 - S3
  • [28] An Exploratory Study to Evaluate the Glycemic Variability by Continuous Glucose Monitoring (CGM) with Insulin Glargine 300 U/mL vs. Glargine 100 U/mL in Patients with Type 2 Diabetes
    Franco, Denise R.
    Visconti, Guilherme D.
    Feder, Cecilia
    Baptista, Juliana
    Vianna, Andre G.
    Guimaraes, Mariana T.
    Souza, Flavia V.
    Tagata, Luciana A.
    Eliaschewitz, Freddy
    DIABETES, 2020, 69
  • [29] Insulin glargine 300 U/ml versus Insulin degludec 100 U/ml Direct Comparison of long-acting Insulins
    Stiefelhagen, Peter
    AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2019, 12 (01): : 38 - 38
  • [30] Is hypoglycaemia a modifiable patient risk in type 2 diabetes: A pooled analysis of insulin glargine 300 U/mL (Gla-300) vs 100U/mL (Gla-100) trials?
    Zhang, Q.
    Rosenstock, J.
    Gerrits, C.
    Liao, L.
    Chew, P.
    DIABETOLOGIA, 2015, 58 : S472 - S472
12345